Myriad Genetics, Inc. removed
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
13.09 USD | +4.14% |
|
+1.24% | -4.52% |
Feb. 05 | Myriad Genetics Get 2 Patents for Molecular Residual Disease Assay | MT |
Feb. 05 | Myriad Genetics Announces Two New Patents Granted For Its Molecular Residual Disease (MRD) Assay | RE |

Quarterly revenue - Rate of surprise
- Stock Market
- Equities
- MYGN Stock
- News Myriad Genetics, Inc.
- Myriad Genetics, Inc.(NasdaqGS: MYGN) dropped from NASDAQ Biotechnology Index